Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Vertex Pharmaceuticals Incorporated    VRTX   US92532F1003

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/21/2014 08/22/2014 08/25/2014 08/26/2014 08/27/2014 Date
88.99(c) 90.22(c) 91.76(c) 93.64(c) 93.33 Last
1 007 361 862 435 971 946 1 899 755 383 095 Volume
-2.53% +1.38% +1.71% +2.05% -0.33% Change
More quotes
Company
Vertex Pharmaceuticals, Inc. is engaged in the business of discovering, developing, manufacturing and commercializing small molecule drugs. The company's research focuses on cystic fibrosis; infectious diseases, including viral infections, such as influenza, and bacterial infections; autoimmune... 
Sector
Pharmaceuticals
Calendar
10/27Earnings Release
Surperformance© rating of Vertex Pharmaceuticals Inc
Trading Rating : Investor Rating :
More about the company
Chart VERTEX PHARMACEUTICALS INC
Duration : Period :
Vertex Pharmaceuticals Inc Technical Analysis Chart | VRTX | US92532F1003 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 556 M
EBIT 2014 -655 M
Net income 2014 -706 M
Finance 2014 427 M
Yield 2014 -
Sales 2015 1 395 M
EBIT 2015 110 M
Net income 2015 42,9 M
Finance 2015 935 M
Yield 2015 -
PER 2014 -
PER 2015 537,24
EV / Sales 2014 38,5x
EV / Sales 2015 15,0x
Capitalization 21 846 M
More Financials
Latest news on VERTEX PHARMACEUTICALS INC
5d ago VERTEX PHARMACEUTICALS : Assigned Patent
7d ago VERTEX PHARMACEUTICALS : Researchers Submit Patent Application, "Solid Forms of ..
7d ago VERTEX PHARMACEUTICALS : Patent Issued for Isothiazolopyridinones Useful for the..
08/15 VERTEX PHARMACEUTICALS : Assigned Patent
08/13 Biotechs lift Wall Street; Dow back in black for 2014
08/13DJMARKET SNAPSHOT : U.S. Stocks Push Higher; Biotechs Rally
08/13 VERTEX PHARMACEUTICALS : New Findings on Medicinal Chemistry Described by Invest..
08/11 S&P 500 MOVERS : Vrtx, kmi
08/11 NASDAQ 100 MOVERS : Ilmn, tsla
08/08 VERTEX PHARMACEUTICALS : Assigned Patent
08/06 VERTEX PHARMACEUTICALS : Receives European Approval for KALYDECO™ ivacafto..
08/06 VERTEX PHARMACEUTICALS : Patent Application Titled "Dosage Units of 3-(6-(1-(2,2..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Technical analysis
Income Statement Evolution
Vertex Pharmaceuticals Inc : Income Statement Evolution
More Financials
EPS Revisions
Vertex Pharmaceuticals Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF